XML 48 R33.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Benefit Plans (Tables) | 12 Months Ended
--- | ---
Oct. 01, 2022
Compensation Related Costs [Abstract] |
Schedule of Stock Option and SARs Activity | A summary of the Company’s stock option and SAR activity follows:
|  | Number of Options/SARs (in thousands) |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value (in thousands)
Outstanding as of September 28, 2019 |  | 464 |  |  | $ | 38.28 |  |  |
Granted |  | — |  |  | — |  |  |
Canceled |  | (16) |  |  | 31.74 |  |  |
Exercised |  | (325) |  |  | 39.78 |  |  |
Outstanding as of October 3, 2020 |  | 123 |  |  | $ | 35.12 |  |  |
Granted |  | — |  |  | — |  |  |
Canceled |  | — |  |  | — |  |  |
Exercised |  | (106) |  |  | 34.12 |  |  |
Outstanding as of October 2, 2021 |  | 17 |  |  | $ | 41.40 |  |  |
Granted |  | — |  |  | — |  |  |
Canceled |  | — |  |  | — |  |  |
Exercised |  | (12) |  |  | 40.32 |  |  |
Outstanding as of October 1, 2022 |  | 5 |  |  | $ | 44.02 |  |  | $ | 215 |
|  | Number of Options/SARs (in thousands) |  | Weighted Average Exercise Price |  | Weighted Average Remaining Life (years) |  | Aggregate Intrinsic Value (in thousands)
Exercisable as of: |  |  |  |  |  |  |  |
October 3, 2020 |  | 123 |  |  | $ | 35.12 |  |  |  |  |
October 2, 2021 |  | 17 |  |  | $ | 41.40 |  |  |  |  |
October 1, 2022 |  | 5 |  |  | $ | 44.02 |  |  | 3.46 |  | $ | 215 |
Schedule of Stock Option and SARs Information | The following table summarizes outstanding stock option and SAR information as of October 1, 2022 (Options/SARs in thousands):
Range of Exercise Prices |  | Number of Options/SARs Outstanding (in thousands) |  | Weighted Average Exercise Price |  | Weighted Average Remaining Life (years) |  | Number of Options / SARs Exercisable (in thousands) |  | Weighted Average Exercise Price
$33.06 - $40.64 |  | 1 |  |  | $ | 37.80 |  |  | 1.26 |  | 1 |  |  | $ | 37.80 |
$40.65 - $41.01 |  | — |  |  | $ | 41.01 |  |  | 1.80 |  | — |  |  | $ | 41.01 |
$41.02 - $44.48 |  | — |  |  | $ | 44.48 |  |  | 1.56 |  | — |  |  | $ | 44.48 |
$44.49 - $45.45 |  | 4 |  |  | $ | 45.45 |  |  | 4.08 |  | 4 |  |  | $ | 45.45 |
$33.06 - $45.45 |  | 5 |  |  | $ | 44.02 |  |  | 3.46 |  | 5 |  |  | $ | 44.02 |
Schedule of PSU and RSU Activity | A summary of the Company’s PSU and RSU activity follows:
|  | Number of Shares (in thousands) |  | Weighted Average Fair Value at Date of Grant |  | Aggregate Intrinsic Value (in thousands)
Units outstanding as of September 28, 2019 |  | 962 |  |  | $ | 56.97 |  |  |
Granted |  | 377 |  |  | 75.91 |  |  |
Canceled |  | (37) |  |  | 60.95 |  |  |
Vested |  | (451) |  |  | 54.85 |  |  |
Units outstanding as of October 3, 2020 |  | 851 |  |  | $ | 66.33 |  |  |
Granted |  | 360 |  |  | 81.15 |  |  |
Canceled |  | (10) |  |  | 70.12 |  |  |
Vested |  | (340) |  |  | 64.00 |  |  |
Units outstanding as of October 2, 2021 |  | 861 |  |  | $ | 72.38 |  |  |
Granted |  | 328 |  |  | 75.39 |  |  |
Canceled |  | (35) |  |  | 76.68 |  |  |
Vested |  | (356) |  |  | 58.76 |  |  |
Units outstanding as of October 1, 2022 |  | 798 |  |  | $ | 79.57 |  |  | $ | 69,889 |

X
- References No definition available. + Details
Name: | us-gaap_CompensationRelatedCostsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration